These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32494156)

  • 1. Erratum: Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern] [Erratum].
    Onco Targets Ther; 2020; 13():4019. PubMed ID: 32494156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study.
    Huang L; Li GM; Zhu JY; Li Z; Li T; Leng XS
    Onco Targets Ther; 2012; 5():457-62. PubMed ID: 23277740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern].
    Onco Targets Ther; 2020; 13():3289. PubMed ID: 32368087
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
    Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
    Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
    Mazzaferro V; Llovet JM; Miceli R; Bhoori S; Schiavo M; Mariani L; Camerini T; Roayaie S; Schwartz ME; Grazi GL; Adam R; Neuhaus P; Salizzoni M; Bruix J; Forner A; De Carlis L; Cillo U; Burroughs AK; Troisi R; Rossi M; Gerunda GE; Lerut J; Belghiti J; Boin I; Gugenheim J; Rochling F; Van Hoek B; Majno P;
    Lancet Oncol; 2009 Jan; 10(1):35-43. PubMed ID: 19058754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
    Tsuchiya K; Asahina Y; Tamaki N; Yasui Y; Hosokawa T; Ueda K; Nakanishi H; Itakura J; Kurosaki M; Enomoto N; Izumi N
    Liver Transpl; 2014 Mar; 20(3):291-7. PubMed ID: 24734314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Gunsar F
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):59-64. PubMed ID: 28302001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Corrigendum].
    Onco Targets Ther; 2020; 13():12253-12254. PubMed ID: 33273830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.
    Qu Z; Ling Q; Gwiasda J; Xu X; Schrem H; Beneke J; Kaltenborn A; Krauth C; Mix H; Klempnauer J; Emmanouilidis N
    Langenbecks Arch Surg; 2018 Aug; 403(5):643-654. PubMed ID: 30120543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.
    Xia W; Ke Q; Guo H; Wang W; Zhang M; Shen Y; Wu J; Xu X; Yan S; Yu J; Zhang M; Zheng S
    BMC Cancer; 2017 Jan; 17(1):14. PubMed ID: 28056901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
    Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
    J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria.
    Ikegami T; Shimada M; Imura S; Yoshizumi T; Arakawa Y; Tokunaga T; Morine Y; Kanemura H
    Transplantation; 2008 Sep; 86(5):641-6. PubMed ID: 18791443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Transplantation After Neoadjuvant Sorafenib Therapy: Preliminary Experience and Literature Review.
    Golse N; Radenne S; Rode A; Ducerf C; Mabrut JY; Merle P
    Exp Clin Transplant; 2018 Apr; 16(2):227-236. PubMed ID: 27212671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in criteria for liver transplantation in hepatocellular carcinoma.
    Parikh ND; Yopp A; Singal AG
    Curr Opin Gastroenterol; 2016 May; 32(3):182-8. PubMed ID: 26992197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular Carcinoma and Liver Transplantation: State of the Art.
    Mancuso A; Perricone G
    J Clin Transl Hepatol; 2014 Sep; 2(3):176-81. PubMed ID: 26357625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy.
    Canter RJ; Patel SA; Kennedy T; D'Angelica MI; Jarnagin WR; Fong Y; Blumgart LH; Freeman RB; DeMatteo RP; Abt PL
    Am J Clin Oncol; 2011 Oct; 34(5):466-71. PubMed ID: 20938319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Xu X; Lu D; Ling Q; Wei X; Wu J; Zhou L; Yan S; Wu L; Geng L; Ke Q; Gao F; Tu Z; Wang W; Zhang M; Shen Y; Xie H; Jiang W; Wang H; Zheng S
    Gut; 2016 Jun; 65(6):1035-41. PubMed ID: 25804634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum:
    Ther Clin Risk Manag; 2020; 16():415. PubMed ID: 32494147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of sorafenib in the prevention and treatment of hepatocellular carcinoma recurrences after liver transplantation].
    Hu AB; He XS; Tai Q; Zhu XF; Ma Y; Wang DP; Wang GD; Wu LW; Ju WQ; Huang JF
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(18):1264-7. PubMed ID: 22883065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.